Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Reuters Investment Profile
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Elbit Medical Technologies Ltd's Subsidiary Receives CE Approval For ExAblate System
Elbit Medical Technologies Ltd announced that its subsidiary, InSightec, has received Council of Europe (CE) mark approval for its ExAblate System. The ExAblate system is a radiation-free treatment that provides pain relief for individuals suffering from bone tumor pain.
Latest Developments for Elbit Medical Technologies Ltd
Latest Key Developments in Advanced
- Hologic Inc Receives FDA Approval For New Low-dose 3D Mammography (Breast Tomosynthesis) Solution For Breast Cancer Screening
- Echo Therapeutics Inc Announces Institutional Review Board (IRB) Approval For Clinical Trial Of Symphony CGM System
- Neovasc Inc Announces Registry Data Presented At Europcr 2013 Confirms the Neovasc Reducer Improves Cardiovascular Parameters In Refractory Angina Patients
- Elekta AB's Chairman Akbar Seddigh Declines Reelection
- Share this
- Link this
- Digg this
Follow Reuters